Catalyst Wire Dossier Catalyst Wire Dossier

OROS Oybutynin

oxybutynin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OROS Oybutynin, covering 2011-05-19 to 2011-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence [Phase 3]

See pricing